Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg
NCT00647660
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg
DRUG:
Corzide® Tablets 80 mg/5 mg
Sponsor
Mylan Pharmaceuticals Inc